408 related articles for article (PubMed ID: 25066021)
1. Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors.
Slobbe P; Windhorst AD; Stigter-van Walsum M; Schuit RC; Smit EF; Niessen HG; Solca F; Stehle G; van Dongen GA; Poot AJ
Nucl Med Biol; 2014 Oct; 41(9):749-57. PubMed ID: 25066021
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors.
Abourbeh G; Dissoki S; Jacobson O; Litchi A; Ben Daniel R; Laki D; Levitzki A; Mishani E
Nucl Med Biol; 2007 Jan; 34(1):55-70. PubMed ID: 17210462
[TBL] [Abstract][Full Text] [Related]
3. Biological evaluation of 3-[(18)F]fluoro-α-methyl-D-tyrosine (D-[(18)F]FAMT) as a novel amino acid tracer for positron emission tomography.
Ohshima Y; Hanaoka H; Tominaga H; Kanai Y; Kaira K; Yamaguchi A; Nagamori S; Oriuchi N; Tsushima Y; Endo K; Ishioka NS
Ann Nucl Med; 2013 May; 27(4):314-24. PubMed ID: 23337966
[TBL] [Abstract][Full Text] [Related]
4. Radiosynthesis and biological evaluation of
Huang S; Han Y; Chen M; Hu K; Qi Y; Sun P; Wang M; Wu H; Li G; Wang Q; Du Z; Zhang K; Zhao S; Zheng X
Bioorg Med Chem Lett; 2018 Apr; 28(6):1143-1148. PubMed ID: 29486966
[TBL] [Abstract][Full Text] [Related]
5. A fully automated two-step synthesis of an (18)F-labelled tyrosine kinase inhibitor for EGFR kinase activity imaging in tumors.
Kobus D; Giesen Y; Ullrich R; Backes H; Neumaier B
Appl Radiat Isot; 2009 Nov; 67(11):1977-84. PubMed ID: 19695886
[TBL] [Abstract][Full Text] [Related]
6. Single step 18F-labeling of dimeric cycloRGD for functional PET imaging of tumors in mice.
Li Y; Liu Z; Lozada J; Wong MQ; Lin KS; Yapp D; Perrin DM
Nucl Med Biol; 2013 Nov; 40(8):959-66. PubMed ID: 24090672
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Imaging of the Programmed Death Ligand 1 by
González Trotter DE; Meng X; McQuade P; Rubins D; Klimas M; Zeng Z; Connolly BM; Miller PJ; O'Malley SS; Lin SA; Getty KL; Fayadat-Dilman L; Liang L; Wahlberg E; Widmark O; Ekblad C; Frejd FY; Hostetler ED; Evelhoch JL
J Nucl Med; 2017 Nov; 58(11):1852-1857. PubMed ID: 28588151
[TBL] [Abstract][Full Text] [Related]
8. Retention Kinetics of the 18F-Labeled Sympathetic Nerve PET Tracer LMI1195: Comparison with 11C-Hydroxyephedrine and 123I-MIBG.
Werner RA; Rischpler C; Onthank D; Lapa C; Robinson S; Samnick S; Javadi M; Schwaiger M; Nekolla SG; Higuchi T
J Nucl Med; 2015 Sep; 56(9):1429-33. PubMed ID: 26182969
[TBL] [Abstract][Full Text] [Related]
9. Two anti-angiogenic TKI-PET tracers, [(11)C]axitinib and [(11)C]nintedanib: Radiosynthesis, in vivo metabolism and initial biodistribution studies in rodents.
Slobbe P; Poot AJ; Haumann R; Schuit RC; Windhorst AD; van Dongen GA
Nucl Med Biol; 2016 Oct; 43(10):612-24. PubMed ID: 27497236
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM
J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
[TBL] [Abstract][Full Text] [Related]
11. Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography.
Iommelli F; De Rosa V; Gargiulo S; Panico M; Monti M; Greco A; Gramanzini M; Ortosecco G; Fonti R; Brunetti A; Del Vecchio S
Clin Cancer Res; 2014 Sep; 20(18):4806-15. PubMed ID: 25052479
[TBL] [Abstract][Full Text] [Related]
12. Semi-automatic synthesis and biodistribution of N-(2-
Wen F; Nie D; Hu K; Tang G; Yao S; Tang C
BMC Med Imaging; 2017 Apr; 17(1):27. PubMed ID: 28431519
[TBL] [Abstract][Full Text] [Related]
13. 18F-Fluorosulfate for PET Imaging of the Sodium-Iodide Symporter: Synthesis and Biologic Evaluation In Vitro and In Vivo.
Khoshnevisan A; Chuamsaamarkkee K; Boudjemeline M; Jackson A; Smith GE; Gee AD; Fruhwirth GO; Blower PJ
J Nucl Med; 2017 Jan; 58(1):156-161. PubMed ID: 27539841
[TBL] [Abstract][Full Text] [Related]
14. [
Amor-Coarasa A; Kelly J; Ponnala S; Vedvyas Y; Nikolopoulou A; Williams C; Jin MM; David Warren J; Babich JW
Nucl Med Biol; 2018 May; 60():37-44. PubMed ID: 29544122
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.
Velikyan I; Sundberg AL; Lindhe O; Höglund AU; Eriksson O; Werner E; Carlsson J; Bergström M; Långström B; Tolmachev V
J Nucl Med; 2005 Nov; 46(11):1881-8. PubMed ID: 16269603
[TBL] [Abstract][Full Text] [Related]
16. 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer.
Zannetti A; Iommelli F; Speranza A; Salvatore M; Del Vecchio S
J Nucl Med; 2012 Mar; 53(3):443-50. PubMed ID: 22331221
[TBL] [Abstract][Full Text] [Related]
17. Radiohalogenated 4-anilinoquinazoline-based EGFR-TK inhibitors as potential cancer imaging agents.
Neto C; Fernandes C; Oliveira MC; Gano L; Mendes F; Kniess T; Santos I
Nucl Med Biol; 2012 Feb; 39(2):247-60. PubMed ID: 22079040
[TBL] [Abstract][Full Text] [Related]
18. Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide.
Dijkgraaf I; Terry SY; McBride WJ; Goldenberg DM; Laverman P; Franssen GM; Oyen WJ; Boerman OC
Contrast Media Mol Imaging; 2013; 8(3):238-45. PubMed ID: 23606427
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of novel
Chong Y; Chang J; Zhao W; He Y; Li Y; Zhang H; Qi C
J Labelled Comp Radiopharm; 2018 Feb; 61(2):42-53. PubMed ID: 28833405
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]